San Pun, PhD

CEO
Aimorphous Health
Courroux, Jura, Switzerland

San Pun, founder of Aimorphous Health, has recent discovered a novel biomarker applicable to solve some of the challenging needs in thrombosis & hemostasis. As a PhD scientist in life sciences, he has many years of experience in biomarker and assay product development for clinical use. Aimorphous Health develops an AI-powered blood diagnostic device to help prevent and treat the #1 cause of death, achieve longevity, healthcare sustainability & equity.

Presentation(s):

• PB1050 - A novel fibrinogen assay not interfered by clot-inhibiting metabolites, FDPs, to help determine the cause of bleeding

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT